The global companion diagnostics market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027. More Info:- https://www.imarcgroup.com/companion-diagnostics-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Companion Diagnostics
Market Research and Forecast
Report 2022-2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Companion Diagnostics Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled "Companion Diagnostics Market: Global
Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global companion
diagnostics market size reached US$ 5.0 Billion in 2021.
Companion diagnostic is an in-vitro diagnostic testing kit, consisting of a combination of tests and
therapies that are used for the development of personalized medicines. It is used to determine the
personal molecular profile of patients that aids healthcare professionals in deciding upon the
approach for their treatment. It also offers information regarding the safe and effective use of a
certain corresponding drug or biological product.
Its usage assists in delivering safe and effective medical care to patients by analyzing the responders
and non-responders to the therapy and offering an in-depth understanding of the biology of their
disease. Currently, these kits are widely used in oncology for drug discovery and delivering targeted
therapies to individuals.
Request for a PDF sample of this report: https://www.imarcgroup.com/companion-diagnostics-
market/requestsample

4. Report Description
Report Description and Highlights
Global Companion Diagnostics Market Trends:
The market is primarily driven by the increasing incidences of various forms of cancer on the global
level. Companion diagnostics are widely used in advanced oncology healthcare for targeting biomarker
identification and delivering targeted therapies to patients, thereby providing a thrust to the market
growth. There has also been a significant increase in the demand for in-vitro diagnostics among the
masses. This, along with the growing preference for personalized healthcare (PHC) and precision
medicine in the healthcare sector, is facilitating the uptake of these diagnostics. Apart from this, there
has been a rise in the utilization of targeted drugs and therapies for treating several infectious,
cardiovascular, neurological, and inflammatory conditions. Coupled with the development of next-
generation sequencing (NGS) and the increasing number of clinical trials, this is creating a positive
outlook for the market.
Additionally, several regulatory bodies, such as the US Food and Drug Administration (US FDA), have
provided a defined structure for companion diagnostic development while encouraging the market
players to conduct research activities in this field. The continual launch of new biomarkers, as well as
the increasing number of collaborations between two or more companies for developing novel
companion diagnostic products, is also providing an impetus to the market growth.

5. Report Description
Report Description and Highlights
Looking forward, IMARC Group expects the market is anticipated to grow at a CAGR of 14.78% during
2022-2027.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/companion-diagnostics-market

6. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Product & Service:
•Assays, Kits and Reagents
•Software and Services
Breakup by Technology:
•Immunohistochemistry (IHC)
•Polymerase Chain Reaction (PCR)
•In-situ Hybridization (ISH)
•Real-time PCR (RT-PCR)
•Gene Sequencing
•Others
Breakup by Indication:
•Cancer
o Lung Cancer
o Breast Cancer

7. Report Description
Report Description and Highlights
o Colorectal Cancer
o Gastric Cancer
o Melanoma
o Others
•Neurological Diseases
•Infectious Diseases
•Cardiovascular Diseases
•Others
Breakup by End User:
•Pharmaceutical & Biopharmaceutical Companies
•Reference Laboratories
•Contract Research Organizations
•Others
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

8. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•Abbott Laboratories
•Agilent Technologies
•BioMerieux
•Danaher Corporation
•Roche Holding AG
•Myriad Genetics Inc
•Siemens Healthcare
•Thermo Fisher Scientific Inc

9. Report Description
Key Questions Answered in the Report
1. What was the size of the global companion diagnostics market in 2021?
2. What is the expected growth rate of the global companion diagnostics market during 2022-
2027?
3. What has been the impact of COVID-19 on the global companion diagnostics market?
4. What are the key factors driving the global companion diagnostics market?
5. What is the breakup of the global companion diagnostics market based on the product &
service?
6. What is the breakup of the global companion diagnostics market based on the technology?
7. What is the breakup of the global companion diagnostics market based on the indication?
8. What is the breakup of the global companion diagnostics market based on the end user?
9. What are the key regions in the global companion diagnostics market?
10. Who are the key players/companies in the global companion diagnostics market?

10. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Companion Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

11. Report Description Table of Contents
6 Market Breakup by Product & Service
6.1 Assays, Kits and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Software and Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Immunohistochemistry (IHC)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Polymerase Chain Reaction (PCR)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 In-situ Hybridization (ISH)
7.3.1 Market Trends
7.3.2 Market Forecast
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/companion-diagnostics-market/toc

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

14. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

15. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us